tiprankstipranks
Trending News
More News >
Sensus Healthcare, Inc. (SRTS)
:SRTS
US Market
Advertisement

Sensus Healthcare (SRTS) Earnings Dates, Call Summary & Reports

Compare
428 Followers

Earnings Data

Report Date
Feb 05, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
-0.07
Last Year’s EPS
0.09
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 06, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive and negative aspects. While there were significant achievements such as the introduction of dedicated CPT codes, growth in treatment volumes, and a strong cash position, these were offset by decreased revenues, lower gross margins, increased operating expenses, and a net loss for the quarter.
Company Guidance
During the Sensus Healthcare Third Quarter 2025 Financial Results Conference Call, the company announced significant guidance on several fronts. They highlighted that the Centers for Medicare & Medicaid Services (CMS) had published new CPT codes for superficial radiotherapy (SRT), leading to a reimbursement increase of over 300% per fraction. This move is expected to bolster demand for SRT systems, and Sensus has already communicated this development to its customer base. In Q3 2025, the company shipped 16 SRT systems, including three to China, and reported a 20% increase in FDA treatment volumes from the second quarter, marking a 52% rise compared to the first quarter and a 157% increase since the program's launch. Financially, Sensus ended the quarter with $24.5 million in cash, up from $22 million at the end of 2024, and maintained strong inventory levels with close to 100 SRT systems. The company anticipates reaching 1,000 systems sold globally by 2026 and sees international expansion opportunities, particularly in markets like China, Japan, Canada, Brazil, and Australia. Despite a decrease in quarterly revenues to $6.9 million from $8.8 million in Q3 2024 and a net loss of $0.9 million, Sensus remains optimistic about the future, driven by the new coding, strong balance sheet, and growing demand for noninvasive treatment options.
Introduction of Dedicated CPT Codes for SRT
CMS published first-ever dedicated CPT codes for superficial radiotherapy (SRT) in nonmelanoma, skin cancer, and keloids, increasing reimbursement per fraction by more than 300%.
Strong Growth in Treatment Volumes
FDA treatment volumes increased 20% from the second quarter and 52% compared to the first quarter, with a 157% increase since the program's launch.
Solid Cash Position
Sensus Healthcare ended the quarter with $24.5 million in cash, up from approximately $22 million at the end of 2024, driven by improved working capital management.
International Expansion Efforts
Shipped 3 SRT systems to China and made progress with international expansion into markets like Canada, Brazil, Japan, and Australia with MDSAP certification.

Sensus Healthcare (SRTS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SRTS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 05, 2026
2025 (Q4)
-0.07 / -
0.09
Nov 06, 2025
2025 (Q3)
-0.10 / -0.06
0.07-185.71% (-0.13)
Aug 07, 2025
2025 (Q2)
0.03 / -0.06
0.1-160.00% (-0.16)
May 15, 2025
2025 (Q1)
0.03 / -0.16
0.14-214.29% (-0.30)
Feb 05, 2025
2024 (Q4)
0.12 / 0.09
0.26-65.38% (-0.17)
Nov 14, 2024
2024 (Q3)
-0.01 / 0.07
-0.09177.78% (+0.16)
Aug 08, 2024
2024 (Q2)
0.02 / 0.10
-0.02600.00% (+0.12)
May 09, 2024
2024 (Q1)
-0.04 / 0.14
-0.12216.67% (+0.26)
Feb 08, 2024
2023 (Q4)
0.14 / 0.26
0.1752.94% (+0.09)
Nov 09, 2023
2023 (Q3)
-0.02 / -0.09
0.11-181.82% (-0.20)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

SRTS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 06, 2025
$3.52$4.20+19.32%
Aug 07, 2025
$5.35$3.46-35.33%
May 15, 2025
$4.66$4.46-4.29%
Feb 05, 2025
$8.99$6.08-32.37%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Sensus Healthcare, Inc. (SRTS) report earnings?
Sensus Healthcare, Inc. (SRTS) is schdueled to report earning on Feb 05, 2026, After Close (Confirmed).
    What is Sensus Healthcare, Inc. (SRTS) earnings time?
    Sensus Healthcare, Inc. (SRTS) earnings time is at Feb 05, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SRTS EPS forecast?
          SRTS EPS forecast for the fiscal quarter 2025 (Q4) is -0.07.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis